Google-Backed Isomorphic Labs Secures $600M to Fuel AI Drug Discovery
Summary
Google-backed AI drug discovery startup Isomorphic Labs secured a staggering $600 million in funding led by Thrive Capital, fueling its AI engine's development and advancing partnerships with pharmaceutical giants like Eli Lilly and Novartis worth billions to revolutionize drug design.
Key Points
- Google-backed Isomorphic Labs raised $600 million in its first external funding round led by Thrive Capital
- The funding will accelerate the development of Isomorphic's AI drug design engine and help advance its programs into clinical trials
- Isomorphic has secured major AI drug discovery partnerships with pharmaceutical companies like Eli Lilly and Novartis worth billions of dollars